Table 1 Patient characteristics.

From: Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes

 

n

Sex (% female)

Mean age (years) (1st, 3rd quartiles)

Karyotypic lesions (proportion)

 
    

Normal

−5/−5q

−7

Trisomy 8

−Ya

Complex

Median survival (years)

AML

612

45.8

63.42 (54.38,75.20)

0.367

0.077

0.088

0.103

0.066

0.203

1.41

MDS

640

42.7

71.07 (66.50,78.00)

0.609

0.189

0.025

0.044

0.114

0.028

6.14

MDS/MPN

264

40.2

74.71 (70.78,80.72)

0.712

0.008

0.042

0.131

0.045

0.027

5.36

MPN

354

36.7

62.79 (53.90,73.75)

0.555

0.012

0.009

0.046

0.039

0.028

18.64

overall

1870

42.2

67.51 (60.85,77.10)

0.533

0.095

0.046

0.076

0.074

0.086

5.71

  1. aCalculated only from male patients.